SAN DIEGO--(BUSINESS WIRE)--PURE Bioscience, Inc. (OTCQB: PURE), creator of the patented silver dihydrogen citrate (SDC) antimicrobial, announced today that on December 14, 2016 the Company will file its Form 10-Q shortly after the close of the market. It will host an investor conference call that day at 1:30pm PST (4:30pm EST) to review 2017 Q1 financial results.
